Clincosm LogoSign in Get a demo

stage iiic breast cancer ajcc v7

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

Active, not recruiting
Has Results
  • Locally Advanced Breast Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +3 more
Jan 31, 2023

HER2/Neu Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Worldwide (drug, other, biological)

Active, not recruiting
Has Results
  • HER2/Neu Positive
  • +8 more
  • Anniston, Alabama
  • +1291 more
Jan 28, 2023

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

Active, not recruiting
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • +19 more
  • Gilbert, Arizona
  • +4 more
Dec 6, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

Recruiting
  • BRCA1 Gene Mutation
  • +19 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • New Brunswick, New Jersey
  • +1 more
Nov 16, 2022

Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States

Recruiting
  • Stage 0 Breast Cancer AJCC v6 and v7
  • +10 more
  • Telemedicine
  • +6 more
  • Washington Township, New Jersey
  • +4 more
Oct 18, 2022

Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Stage II Breast Cancer AJCC v6 and v7
  • +6 more
  • Behavioral, Psychological or Informational Intervention
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States

Recruiting
  • Invasive Breast Carcinoma
  • +8 more
  • Hypofractionated Radiation Therapy
  • +4 more
  • Gilbert, Arizona
  • +8 more
Jun 23, 2022

Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory

Suspended
  • Breast Adenocarcinoma
  • +4 more
  • Eribulin Mesylate
  • +3 more
  • Scottsdale, Arizona
  • +38 more
May 25, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Conroe, Texas
  • +4 more
May 3, 2022

Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,

Recruiting
  • Breast Adenocarcinoma
  • +8 more
  • Birmingham, Alabama
  • +667 more
Apr 6, 2022

Positive Axillary Lymph Node, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7 Trial in Los Angeles

Completed
  • Positive Axillary Lymph Node
  • +11 more
  • Implanted Medical Device
  • Therapeutic Conventional Surgery
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022

Cancer Survivor, Stage I Breast Cancer AJCC v7, Stage I Colon Cancer AJCC v6 and v7 Trial in Scottsdale (American Ginseng,

Completed
  • Cancer Survivor
  • +19 more
  • American Ginseng
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Mar 22, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Stage 0 Breast Cancer AJCC v6 and v7 Trial in Los Angeles,

Active, not recruiting
  • Breast Ductal Carcinoma In Situ
  • +12 more
  • Endoxifen Hydrochloride
  • +2 more
  • Los Angeles, California
  • +2 more
Mar 8, 2022

Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in Puerto Rico,

Active, not recruiting
Has Results
  • Male Breast Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Tucson, Arizona
  • +317 more
Mar 1, 2022

Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Houston (Carboplatin,

Recruiting
  • Stage I Breast Cancer AJCC v7
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Breast Adenocarcinoma
  • +6 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 14, 2021

Breast Adenocarcinoma, HER2/Neu Negative, Locally Advanced Breast Carcinoma Trial in South Africa, United States (Entinostat,

Active, not recruiting
Has Results
  • Breast Adenocarcinoma
  • +9 more
  • Birmingham, Alabama
  • +662 more
Oct 18, 2021